医师资格证
在线问诊
私人医生
团队接诊
黑虎，男，甲状腺头颈科副主任，医学博士，主任医师，留美访问学者，硕士生导师。2004年毕业于郑州大学医学院；2008年毕业于首都医科大学，获耳鼻咽喉头颈外科专业硕士学位。2014年9月至2016年8月，受医院“百人出国留学计划”资助赴美国MD Anderson Cancer Center头颈科访问学习。长期从事甲状腺癌及头颈部其它肿瘤的临床诊治及科研工作。科研重心定位在甲状腺癌的临床和基础相关研究。
社会任职
中华预防医学会甲状腺疾病防治专业委员会委员
中国医疗保健国际交流促进会甲状腺疾病防治分会委员
中国抗癌协会甲状腺癌专业委员会青年委员
河南省预防医学会甲状腺疾病预防与控制专业委员会副主任委员
河南省医学会甲状腺外科分会常务委员
河南省健康科技学会甲状腺乳腺腔镜专业委员会副主任委员
获奖荣誉
主持省厅级课题2项，获省厅科技成果奖或新技术引进奖3项
科研成果
先后发表SCI文章16篇，其中第一作者或通讯作者SCI文章10篇；参译专业书籍2部。
发表文章：
1) Hu Hei, Yifei Zhai, Jianwu Qin, Yongping Song. Intermittent Intraoperative Neural Monitoring Technology in Minimally Invasive Video-Assisted Thyroidectomy: A Preliminary Study. J Invest Surg. 2016;29(2):93-7.
2) Hu Hei, Bin Zhou, Jianwu Qin, Yongping Song. Intermittent intraoperative nerve monitoring in thyroid reoperations: Preliminary results of a randomized, single-surgeon study. Head Neck. 2016; 38 Suppl 1:E1993-7.
3) Hu Hei, Yongping Song, Jianwu Qin. A Nomogram Predicting Contralateral Central Neck Lymph Node Metastasis for Papillary Thyroid Carcinoma. J Surg Oncol. 2016;114(6):703-707.
4) Hu Hei, Yongping Song, Jianwu Qin. Individual prediction of lateral neck metastasis risk in patients with unifocal papillary thyroid carcinoma. Eur J Surg Oncol. 2019; 45(6):1039-1045.
5) Hu Hei, Bin Zhou, Wenbo Gong, Chen Zheng, Jianwu Qin. Male patients with papillary thyroid cancer have a higher risk of extranodal extension. Int J Clin Oncol. 2022; 27: 648-654.
6) Hu Hei, Yanqing Li, Ziyu Luo，Xiaofei Chai, He Zhang, Chen Zheng, Bin Zhou, Wenbo Gong, Jianwu Qin. Extranodal extension is an independent predictor of extensive nodal metastasis in T1 papillary thyroid cancer. Langenbeck's Archives of Surgery. 2022;407(4):1647-1652.
7) Hu Hei, Wenbo Gong, Chen Zheng, Bin Zhou, Jianwu Qin. Macroscopic extranodal extension is an independent predictor of lung metastasis in papillary thyroid cancer. Endocrine. 2022; 77(1):73-79.
8) Ziyu Luo, Hu Hei, Jianwu Qin, Chen Zheng, Wenbo Gong. Lymph node ratio in lateral neck is an independent risk factor for recurrence-free survival in papillary thyroid cancer patients with positive lymph nodes. Endocrine. 2022; 78(3):484-490.
9) Hu Hei, Bin Zhou, Wenbo Gong, Chen Zheng, Jugao Fang, Jianwu Qin. Preoperative prediction of central neck metastasis in patients with clinical T1-2N0 papillary thyroid carcinoma. Surgery Today. 2023;53(4):507-512
10) Yanqing Li, Ziyu Luo, Xinxing Wang, Songtao Zhang, Hu Hei, Jianwu Qin. Design of new drugs for medullary thyroid carcinoma. Frontiers in Oncology. 2022;
11) Jonathan R. George, Ying C. Henderson, Michelle D. Williams, Dianna B. Roberts, Hu Hei, Stephen Y. Lai, and Gary L. Clayman. Association of TERT Promoter Mutation, But Not BRAF Mutation, With Increased Mortality in PTC. J Clin Endocrinol Metab, 2015;100(12): E1550-9.
12) Maniakas A, Henderson YC, Hu Hei, et al. Novel anaplastic thyroid cancer PDXs and cell lines: Expanding preclinical models of genetic diversity. The Journal of clinical endocrinology and metabolism. 2021; 106(11): e4652 - e4665.
13）秦建武,黑虎,张松涛,翟翼飞.腔镜辅助甲状腺切除术中喉返神经的显露及保护.肿瘤研究与临床.2010;22(12):804-806.
14）黑虎,秦建武.甲状腺乳头状癌颈侧区清扫术治疗现状.中国肿瘤2015;24(06):448-451.
15）罗子玉,秦建武,房居高,郑晨,龚文博,黑虎. 淋巴结外侵犯和淋巴结转移比率与甲状腺乳头状癌放射性碘难治的相关性. 中华医学杂志. 2022; 102(48): 3856-3861.
